Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders

Hardingham, Giles E., Bading, Hilmar·2010·Nature Reviews Neuroscience

Cited by (1,001)

Items 401–500 of 1,001

  1. Progressive Parkinsonism by acute dysfunction of excitatory amino acid transporters in the rat substantia nigra
    Maxime Assous, Laurence Had‐Aissouni, Paolo Gubellini, Christophe Melon, Imane Nafia, Pascal Salin, Lydia Kerkerian‐Le Goff, Philippe Kachidian · 2014 · Neurobiology of Disease
  2. Mechanisms of NOS1AP action on NMDA receptor-nNOS signaling
    Michael J. Courtney, Lili Li, Yvonne Y. Lai · 2014 · Frontiers in Cellular Neuroscience
  3. Location- and Subunit-Specific NMDA Receptors Determine the Developmental Sevoflurane Neurotoxicity Through ERK1/2 Signaling
    Wenyuan Wang, Lijie Jia, Yan Luo, Honghai Zhang, Fang Cai, Hui Mao, Weicai Xu, Junbiao Fang, Zhiyou Peng, Zhengwen Ma et al. · 2014 · Molecular Neurobiology
  4. Ring finger protein 10 is a novel synaptonuclear messenger encoding activation of NMDA receptors in hippocampus
    Margarita C. Dinamarca, Francesca Guzzetti, Anna Karpova, Dmitry Lim, Nico Mitro, Stefano Musardo, Manuela Mellone, Elena E. Marcello, Jennifer Stanic, Tanmoy Samaddar et al. · 2016 · eLife
  5. Synaptic Activity Drives a Genomic Program That Promotes a Neuronal Warburg Effect
    Carlos Bas Orth, Yan-Wei Tan, David Lau, Hilmar Bading · 2017 · Journal of Biological Chemistry
  6. Pro-death NMDA receptor signaling is promoted by the GluN2B C-terminus independently of Dapk1
    Jamie McQueen, Tomás J. Ryan, Sean McKay, Katie F. M. Marwick, Paul S. Baxter, Sarah M. Carpanini, Thomas M. Wishart, Thomas Henry Gillingwater, Jean C. Manson, David J. A. Wyllie et al. · 2017 · eLife
  7. Anesthetics fragment hippocampal network activity, alter spine dynamics, and affect memory consolidation
    Wei Yang, Mattia Chini, Jastyn A. Pöpplau, Andrey Formozov, Alexander Dieter, Patrick Piechocinski, Cynthia Rais, Fabio Morellini, Olaf Sporns, Ileana L. Hanganu‐Opatz et al. · 2021 · PLoS Biology
  8. Role of neurotransmitters in immune-mediated inflammatory disorders: a crosstalk between the nervous and immune systems
    Mojgan Oshaghi, Masoumeh Kourosh‐Arami, Maryam Roozbehkia · 2022 · Neurological Sciences
  9. NMDA Receptors: Distribution, Role, and Insights into Neuropsychiatric Disorders
    Marie Beaurain, Anne‐Sophie Salabert, Pierre Payoux, Emmanuel Gras, Franck Talmont · 2024 · Pharmaceuticals
  10. Relationship between Zinc (Zn 2+ ) and Glutamate Receptors in the Processes Underlying Neurodegeneration
    Bartłomiej Pochwat, Gabriel Nowak, Bernadeta Szewczyk · 2015 · Neural Plasticity
  11. Osmotic Edema Rapidly Increases Neuronal Excitability Through Activation of NMDA Receptor-Dependent Slow Inward Currents in Juvenile and Adult Hippocampus
    Kelli Lauderdale, Thomas Murphy, Tina Tung, David Davila, Devin K. Binder, Todd A. Fiacco · 2015 · ASN NEURO
  12. Identification of Synaptotagmin 10 as Effector of NPAS4-Mediated Protection from Excitotoxic Neurodegeneration
    Anne Woitecki, Johannes Alexander Müller, Karen M. J. van Loo, Ramona Felizitas Sowade, Albert J. Becker, Susanne Schoch · 2016 · Journal of Neuroscience
  13. N -Methyl-D-Aspartate (NMDA) receptor modulators: a patent review (2015-present)
    Hazem Ahmed, Ahmed Haider, Simon Mensah Ametamey · 2020 · Expert Opinion on Therapeutic Patents
  14. Dysregulation of synaptic and extrasynaptic N-methyl-D-aspartate receptors induced by amyloid-β
    Wang, Zhi-Cong, Zhao, Jie, Li, Shao · 2013 · Neuroscience Bulletin
  15. Neuronal metabotropic glutamate receptor 8 protects against neurodegeneration in CNS inflammation
    Woo, Marcel S., Ufer, Friederike, Rothammer, Nicola, Di Liberto, Giovanni, Binkle, Lars, Haferkamp, Undine, Sonner, Jana K., Engler, Jan Broder, Hornig, Sönke, Bauer, Simone et al. · 2021 · Journal of Experimental Medicine
  16. Involvement of NMDA receptor subtypes in cortical spreading depression in rats assessed by fMRI
    Artem Shatillo, Raimo A. Salo, Rashid A. Giniatullin, Olli H.J. Gröhn · 2015 · Neuropharmacology
  17. HINT1 protein cooperates with cannabinoid 1 receptor to negatively regulate glutamate NMDA receptor activity
    Ana Vicente‐Sánchez, Pilar Sánchez‐Blázquez, María Rodríguez-Muñoz, Javier Garzón · 2013 · Molecular Brain
  18. Are cyclooxygenase-2 and nitric oxide involved in the dyskinesia of Parkinson's disease induced by l -DOPA?
    Mariza Bortolanza, Fernando E. Padovan‐Neto, Roberta Cavalcanti-Kwiatkoski, Maurício dos Santos Pereira, Mišo Mitkovski, Rita Raisman‐Vozari, Elaine Aparecida Del Bel · 2015 · Philosophical Transactions of the Royal Society B Biological Sciences
  19. Bok Is Not Pro-Apoptotic But Suppresses Poly ADP-Ribose Polymerase-Dependent Cell Death Pathways and Protects against Excitotoxic and Seizure-Induced Neuronal Injury
    Beatrice D’Orsi, Tobías Engel, Shona Pfeiffer, Saheli Nandi, Thomas Kaufmann, David Clifford Henshall, Jochen H.M. Prehn · 2016 · Journal of Neuroscience
  20. Altered zinc sensitivity of NMDA receptors harboring clinically-relevant mutations
    Benjamin Serraz, Teddy Grand, Pierre Paoletti · 2016 · Neuropharmacology
  21. Profiling of Signaling Proteins in Penumbra After Focal Photothrombotic Infarct in the Rat Brain Cortex
    Svetlana Viktorovna Demyanenko, Anatoly B. Uzdensky · 2016 · Molecular Neurobiology
  22. Low on energy? An energy supply-demand perspective on stress and depression
    Leif Østergaard, Martin Balslev Jørgensen, Gitte M. Knudsen · 2018 · Neuroscience & Biobehavioral Reviews
  23. Cell-Autonomous and Non-cell-Autonomous Pathogenic Mechanisms in Huntington's Disease: Insights from In Vitro and In Vivo Models
    Jordi Creus‐Muncunill, Michelle E. Ehrlich · 2019 · Neurotherapeutics
  24. GluN2A and GluN2B N-Methyl-D-Aspartate Receptor (NMDARs) Subunits: Their Roles and Therapeutic Antagonists in Neurological Diseases
    Amany Digal Ladagu, Funmilayo Eniola Olopade, Adeboye Adejare, James Olukayode Olopade · 2023 · Pharmaceuticals
  25. Zinc deficiency in rats is associated with up-regulation of hippocampal NMDA receptor
    Urszula Doboszewska, Magdalena Sowa-Kućma, Katarzyna Młyniec, Bartłomiej Pochwat, Małgorzata Hołuj, Beata Ostachowicz, Andrzej Pilc, Gabriel Nowak, Bernadeta Szewczyk · 2014 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  26. Adaptor Protein APPL1 Couples Synaptic NMDA Receptor with Neuronal Prosurvival Phosphatidylinositol 3-Kinase/Akt Pathway
    Yubin Wang, Jiejie Wang, Shaohua Wang, Shuangshuang Liu, Jingyuan Cao, Xiao-ming Li, Shuang Qiu, Jianhong Luo · 2012 · Journal of Neuroscience
  27. The Nuclear Calcium Signaling Target, Activating Transcription Factor 3 (ATF3), Protects against Dendrotoxicity and Facilitates the Recovery of Synaptic Transmission after an Excitotoxic Insult
    Hanna Ahlgren, Carlos Bas Orth, H. Eckehard Freitag, Andrea Hellwig, Ole Petter Ottersen, Hilmar Bading · 2014 · Journal of Biological Chemistry
  28. Between promiscuity and specificity: novel roles of EF‐hand calcium sensors in neuronal Ca2+ signalling
    Marina Mikhaylova, Johannes Hradsky, Michael R. Kreutz · 2011 · Journal of Neurochemistry
  29. Rapid Antidepressant Effect of Hydrogen Sulfide: Evidence for Activation of mTORC1-TrkB-AMPA Receptor Pathways
    Xiao-Yi Hou, Zhuang‐Li Hu, Deng-Zheng Zhang, Wei Lu, Jun Zhou, Peng-Fei Wu, Xin‐Lei Guan, Qian-Qian Han, Si‐Long Deng, Hai Zhang et al. · 2017 · Antioxidants and Redox Signaling
  30. Astrocytic glutamatergic transporters are involved in Aβ-induced synaptic dysfunction
    Shuxuan Huang, Huichun Tong, Ming Lei, Miaomiao Zhou, Wenyuan Guo, Guihua Li, Xiaolu Tang, Zhe Li, Mingshu Mo, Xiuping Zhang et al. · 2017 · Brain Research
  31. Molecular insights into cortico-striatal miscommunications in Huntington's disease
    Matthew B. Veldman, X. William Yang · 2017 · Current Opinion in Neurobiology
  32. Selenium Restores Synaptic Deficits by Modulating NMDA Receptors and Selenoprotein K in an Alzheimer's Disease Model
    Zhong-Hao Zhang, Chen Chen, Shi-Zheng Jia, Xian-Chun Cao, Min Liu, Jing Tian, Peter R. Hoffmann, Huaxi Xu, Jiazuan Ni, Guo-Li Song · 2020 · Antioxidants and Redox Signaling
  33. Efficacy of Lovastatin on Learning and Memory Deficits Caused by Chronic Intermittent Hypoxia-Hypercapnia: Through Regulation of NR2B-Containing NMDA Receptor-ERK Pathway
    Xinlong Huo, Jingjing Min, Cai-yu Pan, Cui-Cui Zhao, Lu-lu Pan, Fei-fei Gui, Jin Lu, Xiaotong Wang · 2014 · PLoS ONE
  34. An Overview of the Involvement of D-Serine in Cognitive Impairment in Normal Aging and Dementia
    Magdalena Orzylowski, Esther Fujiwara, Darrell D. Mousseau, Glen B. Baker · 2021 · Frontiers in Psychiatry
  35. Uncovering the Underlying Mechanisms of Ketamine as a Novel Antidepressant
    Songbai Xu, Xiaoxiao Yao, Bingjin Li, Ranji Cui, Cuilin Zhu, Yao Wang, Wei Yang · 2022 · Frontiers in Pharmacology
  36. L-type Ca2+ channel blockade with antihypertensive medication disrupts VTA synaptic plasticity and drug-associated contextual memory
    Mickaël Degoulet, Claire E. Stelly, K-C Ahn, H Morikawa · 2015 · Molecular Psychiatry
  37. Conformational targeting of intracellular Aβ oligomers demonstrates their pathological oligomerization inside the endoplasmic reticulum
    Giovanni Meli, Agnese Lecci, Annalisa Manca, Nina Krako Jakovljevic, Valentina Albertini, Luisa Benussi, Roberta Ghidoni, Antonino Cattaneo · 2014 · Nature Communications
  38. Pannexin channels and ischaemia
    Roger J. Thompson · 2014 · The Journal of Physiology
  39. NMDA Receptor-Mediated Signaling Pathways Enhance Radiation Resistance, Survival and Migration in Glioblastoma Cells—A Potential Target for Adjuvant Radiotherapy
    Adriana Müller-Längle, Henrik Lutz, Stephanie Hehlgans, Franz Rödel, Kerstin Rau, Bodo Laube · 2019 · Cancers
  40. Glutamate-based depression GBD
    Dennis J. McCarthy, Robert Alexander, Mark A. Smith, Sanjeev Pathak, Stephen Kanes, Chi‐Ming Lee, Gerard Sanacora · 2012 · Medical Hypotheses
  41. The dose makes the poison: From glutamate-mediated neurogenesis to neuronal atrophy and depression
    Rubio-Casillas, Alberto, Fernández-Guasti, Alonso · 2016 · Reviews in the Neurosciences
  42. MK-801 and cognitive functions: Investigating the behavioral effects of a non-competitive NMDA receptor antagonist
    Anna Janus, Klaudia Lustyk, Karolina Pytka · 2023 · Psychopharmacology
  43. Neuropeptide Y promotes neurogenesis and protection against methamphetamine-induced toxicity in mouse dentate gyrus-derived neurosphere cultures
    Sofia Baptista, Ana Rita Bento, Joana Gonçalves, Liliana Inácio Bernardino, Teresa Summavielle, Andrea C. Lobo, Carlos Ribeiro, João Oliveira Malva, Fabienne Agasse, Ana Paula Silva · 2012 · Neuropharmacology
  44. Huntington’s disease and striatal signaling
    Emmanuel Flamand Roze · 2011 · Frontiers in Neuroanatomy
  45. Modulating the Balance of Synaptic and Extrasynaptic NMDA Receptors Shows Positive Effects against Amyloid-β-Induced Neurotoxicity
    Yan You Huang, Wei Shen, Jie Su, Bin Cheng, Dong Li, Gang Liu, Wenxia Zhou, Yongxiang Zhang · 2017 · Journal of Alzheimer s Disease
  46. Positive Allosteric Modulation as a Potential Therapeutic Strategy in Anti-NMDA Receptor Encephalitis
    Natasha Warikoo, Samuel J. Brunwasser, Ann M. Benz, Hong‐Jin Shu, Steven M. Paul, Michael Lewis, James Doherty, Michael C. Quirk, Laura M. Piccio, Charles F. Zorumski et al. · 2018 · Journal of Neuroscience
  47. Novel Positive Allosteric Modulators of Glutamate Transport Have Neuroprotective Properties in an in Vitro Excitotoxic Model
    Romulo Martelli Falcucci, Ryan Wertz, Jennifer Leigh Green, Olimpia Meucci, Joseph M. Salvino, Andréia C. K. Fontana · 2019 · ACS Chemical Neuroscience
  48. The intersections of NMDAR-dependent synaptic plasticity and cell survival
    Thomas E. Bartlett, Yu Tian Wang · 2013 · Neuropharmacology
  49. Nuclear Translocation of Jacob in Hippocampal Neurons after Stimuli Inducing Long-Term Potentiation but Not Long-Term Depression
    Thomas Behnisch, PingAn Yuanxiang, Philipp Bethge, Suhel Parvez, Ying Chen, Jin Ming Yu, Anna Karpova, Julietta Uta Frey, Marina Mikhaylova, Michael R. Kreutz · 2011 · PLoS ONE
  50. Increasing levels of wild-type CREB up-regulates several activity-regulated inhibitor of death (AID) genes and promotes neuronal survival
    Yan-Wei Tan, Sheng‐Jia Zhang, Tina Hoffmann, Hilmar Bading · 2012 · BMC Neuroscience
  51. Mapping the Binding of GluN2B-Selective N-Methyl-d-aspartate Receptor Negative Allosteric Modulators
    Pieter B. Burger, Hongjie Yuan, Erkan Karakaş, Matthew T. Geballe, Hiro Furukawa, Dennis C. Liotta, James P. Snyder, Stephen F. Traynelis · 2012 · Molecular Pharmacology
  52. NR2B Phosphorylation at Tyrosine 1472 Contributes to Brain Injury in a Rodent Model of Neonatal Hypoxia-Ischemia
    Renatta N. Knox, Angela Brennan, Fuxin Lu, Diana Yang, Takanobu Nakazawa, Tadashi S. Yamamoto, Raymond A. Swanson, Donna Marie Ferriero, Xiangning Jiang · 2014 · Stroke
  53. Preferential Inhibition of Tonically over Phasically Activated NMDA Receptors by Pregnane Derivatives
    Vojtěch Vyklický, Tereza Smejkalová, Barbora Hrčka Krausová, Aleš Balík, Miloslav Kořı́nek, Jiřina Borovská, Martin Hořák, Markéta Chvojková, Lenka Kletečková, Karel Valeš et al. · 2016 · Journal of Neuroscience
  54. Geniposide Attenuates Post-Ischaemic Neurovascular Damage via GluN2A/AKT/ ERK-Dependent Mechanism
    Baosheng Huang, Panhong Chen, Lei Huang, Shuai Li, Ronglan Zhu, Tao Sheng, Yu Wan, Zheng Chen, Tianlu Wang · 2017 · Cellular Physiology and Biochemistry
  55. Selective basal ganglia vulnerability to energy deprivation: Experimental and clinical evidences
    Nicola Tambasco, Michele Romoli, Paolo Calabresi · 2018 · Progress in Neurobiology
  56. Impact of Aging in Microglia-Mediated D-Serine Balance in the CNS
    Sebastián Beltrán-Castillo, Jaime L. Eugenín, Rommy von Bernhardi M. · 2018 · Mediators of Inflammation
  57. Glycolytic flux controls d -serine synthesis through glyceraldehyde-3-phosphate dehydrogenase in astrocytes
    Masataka Suzuki, Jumpei Sasabe, Yurika Miyoshi, Kanako Kuwasako, Y. Muto, Kenji Hamase, Masaaki Matsuoka, Nobuaki Imanishi, Sadakazu Aiso · 2015 · Proceedings of the National Academy of Sciences
  58. Astrocytic Ca2+ waves mediate activation of extrasynaptic NMDA receptors in hippocampal neurons to aggravate brain damage during ischemia
    Qiping Dong, Jingquan He, Zhen Chai · 2013 · Neurobiology of Disease
  59. The role of synaptic activity in the regulation of amyloid beta levels in Alzheimer's disease
    Xiaofang Cheng, Jian Wu, Miao Geng, Jiaxiang Xiong · 2013 · Neurobiology of Aging
  60. Enhancing NMDA Receptor Function: Recent Progress on Allosteric Modulators
    Lulu Yao, Qiang Zhou · 2017 · Neural Plasticity
  61. Mechanisms of action and clinical efficacy of NMDA receptor modulators in mood disorders
    Mehdi Ghasemi, Cristy Phillips, Atoossa Fahimi, Margaret Windy McNerney, Ahmad Salehi · 2017 · Neuroscience & Biobehavioral Reviews
  62. Pedunculopontine glutamatergic neurons control spike patterning in substantia nigra dopaminergic neurons
    Daniel J. Galtieri, Chad M. Estep, David L. Wokosin, Stephen F. Traynelis, Dalton James Surmeier · 2017 · eLife
  63. Cocaine use disorder: A look at metabotropic glutamate receptors and glutamate transporters
    Ewa Niedzielska, Lucyna Pomierny-Chamioło, Michał Andres, Maria Walczak, Lori A. Knackstedt, Małgorzata Filip, Edmund Przegaliński · 2021 · Pharmacology & Therapeutics
  64. Dock GEFs and their therapeutic potential: Neuroprotection and axon regeneration
    Namekata, Kazuhiko, Kimura, Atsuko, Kawamura, Kazuto, Harada, Chikako, Harada, Takayuki · 2014 · Progress in Retinal and Eye Research
  65. Regulation of membrane NMDA receptors by dynamics and protein interactions
    Mar Petit‐Pedrol, Laurent Groc · 2020 · The Journal of Cell Biology
  66. Glutamatergic receptor and neuroplasticity in depression: Implications for ketamine and rapastinel as the rapid-acting antidepressants
    Yating Wang, Ningning Zhang, Lingjie Liu, Hong Jiang, Die Hu, Zhen‐Zhen Wang, Nai‐Hong Chen, Yi Zhang · 2022 · Biochemical and Biophysical Research Communications
  67. The translational potential of cholesterol-based therapies for neurological disease
    Marta Valenza, Giulia Birolini, Elena F. Cattaneo · 2023 · Nature Reviews Neurology
  68. Pituitary adenylate cyclase‐activating peptide induces long‐lasting neuroprotection through the induction of activity‐dependent signaling via the cyclic AMP response element‐binding protein‐regulated transcription co‐activator 1
    Paul S. Baxter, Marc‐André Martel, Aoife McMahon, Peter C. Kind, Giles E. Hardingham · 2011 · Journal of Neurochemistry
  69. Eph receptors: New players in Alzheimer's disease pathogenesis
    Moustapha Cissé, Frédéric Checler · 2014 · Neurobiology of Disease
  70. Loss of F-box Only Protein 2 (Fbxo2) Disrupts Levels and Localization of Select NMDA Receptor Subunits, and Promotes Aberrant Synaptic Connectivity
    Graham Atkin, Shannon J. Moore, Yuan Lü, Rick F. Nelson, Nathan Tipper, Gautam Rajpal, Jack F.V. Hunt, William Tennant, Johannes Wilhelm Hell, Geoffrey G. Murphy et al. · 2015 · Journal of Neuroscience
  71. Reciprocal disruption of neuronal signaling and Aβ production mediated by extrasynaptic NMDA receptors: a downward spiral
    Travis Rush, Alain Buisson · 2014 · Cell and Tissue Research
  72. D-Serine and Serine Racemase Are Associated with PSD-95 and Glutamatergic Synapse Stability
    Hong Lin, Ariel A. Jacobi, Stewart A. Anderson, David R. Lynch · 2016 · Frontiers in Cellular Neuroscience
  73. Lineage divergence of activity-driven transcription and evolution of cognitive ability
    Giles E. Hardingham, Priit Pruunsild, Michael E. Greenberg, Hilmar Bading · 2017 · Nature reviews. Neuroscience
  74. Oxoglutarate dehydrogenase complex controls glutamate-mediated neuronal death
    Weidinger, Adelheid, Milivojev, Nadja, Hosmann, Arthur, Duvigneau, J. Catharina, Szabo, Csaba, Törö, Gabor, Rauter, Laurin, Vaglio-Garro, Annette, Mkrtchyan, Garik V., Trofimova, Lidia et al. · 2023 · Redox Biology
  75. Restoration of metal homeostasis: a potential strategy against neurodegenerative diseases
    Yiyue Zhang, Xisheng Li, Kaidi Ren, Jun Peng, Xiu‐Ju Luo · 2023 · Ageing Research Reviews
  76. Excitotoxic stimulation downregulates the ubiquitin–proteasome system through activation of NMDA receptors in cultured hippocampal neurons
    Margarida V. Caldeira, Michele Curcio, Graciano Leal, Ivan L. Salazar, Miranda Mele, Ana Rita Santos, Carlos V. Melo, Paulo Pereira, Lorella M.T. Canzoniero, Carlos Bandeira Duarte · 2012 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  77. Death Associated Protein Kinases: Molecular Structure and Brain Injury
    Syam Nair, Henrik Hagberg, Golgodu Krishnamurthy Rajanikant, Claire Thornton, Carina E. Mallard · 2013 · International Journal of Molecular Sciences
  78. Pannexin-1 as a potentiator of ligand-gated receptor signaling
    Brant E. Isakson, Roger J. Thompson · 2014 · Channels
  79. GluN2A Subunit-Containing NMDA Receptors Are the Preferential Neuronal Targets of Homocysteine
    Dmitry A. Sibarov, Polina A. Abushik, Rashid A. Giniatullin, Sergei M. Antonov · 2016 · Frontiers in Cellular Neuroscience
  80. High-resolution bioelectrical imaging of Aβ-induced network dysfunction on CMOS-MEAs for neurotoxicity and rescue studies
    Hayder Amin, Thierry Ralph Nieus, Davide Lonardoni, Alessandro Maccione, Luca Berdondini · 2017 · Scientific Reports
  81. Synaptic Activity Protects Neurons Against Calcium-Mediated Oxidation and Contraction of Mitochondria During Excitotoxicity
    Constanze Depp, Carlos Bas Orth, Lisa Schroeder, Andrea Hellwig, Hilmar Bading · 2017 · Antioxidants and Redox Signaling
  82. Tau is required for the function of extrasynaptic NMDA receptors
    Noemí Pallas‐Bazarra, Jonathan E. Draffin, Raquel Cuadros, Jose Antonio Esteban, Jesús Ávila · 2019 · Scientific Reports
  83. Female mouse fetal loss mediated by maternal autoantibody
    Wang, Li, Zhou, Dun, Lee, Ji, Niu, Haitao, Faust, Thomas W., Frattini, Stephen, Kowal, Czeslawa, Huerta, Patricio T., Volpe, Bruce T., Diamond, Betty · 2012 · Journal of Experimental Medicine
  84. Protein-protein interactions at the NMDA receptor complex: From synaptic retention to synaptonuclear protein messengers
    Fabrizio Gardoni, Mónica Di Luca · 2021 · Neuropharmacology
  85. NMDA Receptor and Its Emerging Role in Cancer
    Simona Gallo, Annapia Vitacolonna, Tiziana Crepaldi · 2023 · International Journal of Molecular Sciences
  86. Extrasynaptic NMDA Receptor in Excitotoxicity
    Xianju Zhou, Zhuoyou Chen, Wenwei Yun, Jianhua Ren, Chengwei Li, Hongbing Wang · 2014 · The Neuroscientist
  87. Phosphorylation and Assembly of Glutamate Receptors After Brain Ischemia
    Fan Zhang, Ailan Guo, Chunli Liu, Micheal Comb, Bingren Hu · 2012 · Stroke
  88. Estrogen modulation of visceral pain
    Lihong Sun, Wenxin Zhang, Qi Xu, Hui Bing K. Wu, Cuicui Jiao, Xinzhong Chen · 2019 · Journal of Zhejiang University SCIENCE B
  89. Relationships and Interactions between Ionotropic Glutamate Receptors and Nicotinic Receptors in the CNS
    Trevor W. Stone · 2021 · Neuroscience
  90. Riluzole Partially Rescues Age-Associated, but not LPS-Induced, Loss of Glutamate Transporters and Spatial Memory
    Holly M. Brothers, Isabelle Bardou, Sarah C. Hopp, Roxanne M. Kaercher, Angela W. Corona, Ashley M. Fenn, Jonathan P. Godbout, Gary L. Wenk · 2013 · Journal of Neuroimmune Pharmacology
  91. Single-Neuron NMDA Receptor Phenotype Influences Neuronal Rewiring and Reintegration following Traumatic Injury
    Tapan P. Patel, Scott C. Ventre, Donna M. Geddes‐Klein, Pallab K. Singh, David F. Meaney · 2014 · Journal of Neuroscience
  92. Adaptive preconditioning in neurological diseases – therapeutic insights from proteostatic perturbations
    Bertrand Mollereau, Nina Marie Rzechorzek, Benoit Denis Roussel, Marianne Sedru, Daan M. van den Brink, Béatrice Bailly‐Maitre, Francesca Palladino, Danilo B. Medinas, P.M. Domingos, Stéphane Hunot et al. · 2016 · Brain Research
  93. β-amyloid and Oxidative Stress: Perspectives in Drug Development
    Giuseppe Caruso, Simona Federica Spampinato, Vincenzo Cardaci, Filippo Caraci, Maria Angela Sortino, Sara Merlo · 2019 · Current Pharmaceutical Design
  94. Tau as a potential therapeutic target for ischemic stroke
    Xin Chen, Hua Jiang · 2019 · Aging
  95. Age-Dependent Changes in Synaptic NMDA Receptor Composition in Adult Human Cortical Neurons
    Chrysia M. Pegasiou, Ardalan H Zolnourian, Diego Gómez‐Nicola, Katrin Deinhardt, James A. R. Nicoll, Aminul Islam Ahmed, Girish Vajramani, Paul Grundy, Matthijs B Verhoog, Huibert D. Mansvelder et al. · 2020 · Cerebral Cortex
  96. N-methyl-d-aspartate receptor function in neuronal and synaptic development and signaling
    Jessica Pagano, Federica Giona, Stefania Beretta, Chiara Verpelli, Carlo Sala · 2021 · Current Opinion in Pharmacology
  97. The role of N-methyl-D-aspartate glutamate receptors in Alzheimer’s disease: From pathophysiology to therapeutic approaches
    Wenying Liu, Yan Li, Tan Zhao, Min Gong, Xuechu Wang, Yue Zhang, Lingzhi Xu, Wenwen Li, Yan Li, Jianping Jia · 2023 · Progress in Neurobiology
  98. Neuroprotective effects of phenolic antioxidant tBHQ associate with inhibition of FoxO3a nuclear translocation and activity
    Parmvir K. Bahia, Victoria Pugh, Kimberley Hoyland, Victoria Hensley, Marcus Rattray, Robert J. Williams · 2012 · Journal of Neurochemistry
  99. VEGF modulates NMDA receptors activity in cerebellar granule cells through Src-family kinases before synapse formation
    Claire Meissirel, Carmen Ruiz de Almodóvar, Ellen Knevels, Cathy Coulon, Naura Chounlamountri, Inmaculada Segura, Pierre De Rossi, Stefan Vinckier, Kristof Anthonis, Bérangère Deleglise et al. · 2011 · Proceedings of the National Academy of Sciences
  100. Recovery of NMDA receptor currents from MK-801 blockade is accelerated by Mg2+ and memantine under conditions of agonist exposure
    Sean McKay, C. Peter Bengtson, Hilmar Bading, David J. A. Wyllie, Giles E. Hardingham · 2013 · Neuropharmacology